nodes	percent_of_prediction	percent_of_DWPC	metapath
Ziprasidone—CYP3A4—Budesonide—ulcerative colitis	0.0341	0.0885	CbGbCtD
Ziprasidone—CYP3A7—Hydrocortisone—ulcerative colitis	0.0317	0.0822	CbGbCtD
Ziprasidone—CYP3A7-CYP3A51P—Hydrocortisone—ulcerative colitis	0.0317	0.0822	CbGbCtD
Ziprasidone—CYP3A5—Sulfasalazine—ulcerative colitis	0.0296	0.0768	CbGbCtD
Ziprasidone—CYP1A2—Nicotine—ulcerative colitis	0.0283	0.0735	CbGbCtD
Ziprasidone—CYP3A5—Hydrocortisone—ulcerative colitis	0.0237	0.0616	CbGbCtD
Ziprasidone—CYP2D6—Nicotine—ulcerative colitis	0.0233	0.0606	CbGbCtD
Ziprasidone—HTR3A—enteric nervous system—ulcerative colitis	0.0218	0.184	CbGeAlD
Ziprasidone—CYP2D6—Cholecalciferol—ulcerative colitis	0.0209	0.0543	CbGbCtD
Ziprasidone—CYP3A7-CYP3A51P—Dexamethasone—ulcerative colitis	0.0197	0.0511	CbGbCtD
Ziprasidone—CYP3A7—Dexamethasone—ulcerative colitis	0.0197	0.0511	CbGbCtD
Ziprasidone—HTR3A—myenteric nerve plexus—ulcerative colitis	0.0165	0.14	CbGeAlD
Ziprasidone—CYP3A4—Methylprednisolone—ulcerative colitis	0.0152	0.0395	CbGbCtD
Ziprasidone—CYP3A4—Nicotine—ulcerative colitis	0.0148	0.0385	CbGbCtD
Ziprasidone—CYP3A5—Dexamethasone—ulcerative colitis	0.0148	0.0383	CbGbCtD
Ziprasidone—HTR7—enteric nervous system—ulcerative colitis	0.0141	0.119	CbGeAlD
Ziprasidone—CYP3A4—Cholecalciferol—ulcerative colitis	0.0133	0.0345	CbGbCtD
Ziprasidone—CYP3A4—Triamcinolone—ulcerative colitis	0.0115	0.0299	CbGbCtD
Ziprasidone—HTR7—myenteric nerve plexus—ulcerative colitis	0.0107	0.0905	CbGeAlD
Ziprasidone—CYP3A4—Betamethasone—ulcerative colitis	0.0099	0.0257	CbGbCtD
Ziprasidone—CYP3A4—Prednisolone—ulcerative colitis	0.00977	0.0254	CbGbCtD
Ziprasidone—CHRM3—muscle of abdomen—ulcerative colitis	0.00939	0.0795	CbGeAlD
Ziprasidone—CYP3A4—Hydrocortisone—ulcerative colitis	0.00926	0.024	CbGbCtD
Ziprasidone—CYP3A4—Prednisone—ulcerative colitis	0.00922	0.0239	CbGbCtD
Ziprasidone—CYP2D6—Dexamethasone—ulcerative colitis	0.00906	0.0235	CbGbCtD
Ziprasidone—HTR2A—enteric nervous system—ulcerative colitis	0.00879	0.0744	CbGeAlD
Ziprasidone—HTR2A—myenteric nerve plexus—ulcerative colitis	0.00667	0.0564	CbGeAlD
Ziprasidone—CYP3A4—Dexamethasone—ulcerative colitis	0.00576	0.0149	CbGbCtD
Ziprasidone—CHRM5—epithelium—ulcerative colitis	0.002	0.0169	CbGeAlD
Ziprasidone—DRD5—lymphoid tissue—ulcerative colitis	0.00172	0.0145	CbGeAlD
Ziprasidone—H1F0—smooth muscle tissue—ulcerative colitis	0.00166	0.0141	CbGeAlD
Ziprasidone—H1F0—lymphoid tissue—ulcerative colitis	0.00133	0.0112	CbGeAlD
Ziprasidone—CYP3A7—liver—ulcerative colitis	0.00132	0.0112	CbGeAlD
Ziprasidone—H1F0—digestive system—ulcerative colitis	0.00131	0.0111	CbGeAlD
Ziprasidone—HTR3A—digestive system—ulcerative colitis	0.00125	0.0106	CbGeAlD
Ziprasidone—CYP3A7-CYP3A51P—liver—ulcerative colitis	0.00112	0.00948	CbGeAlD
Ziprasidone—CHRM3—smooth muscle tissue—ulcerative colitis	0.00108	0.00911	CbGeAlD
Ziprasidone—HTR7—epithelium—ulcerative colitis	0.00106	0.009	CbGeAlD
Ziprasidone—ADRA1A—epithelium—ulcerative colitis	0.00103	0.00868	CbGeAlD
Ziprasidone—HTR7—smooth muscle tissue—ulcerative colitis	0.00103	0.00868	CbGeAlD
Ziprasidone—H1F0—liver—ulcerative colitis	0.000977	0.00827	CbGeAlD
Ziprasidone—SLC6A4—digestive system—ulcerative colitis	0.000954	0.00807	CbGeAlD
Ziprasidone—CHRM3—digestive system—ulcerative colitis	0.00085	0.0072	CbGeAlD
Ziprasidone—HTR7—digestive system—ulcerative colitis	0.000809	0.00685	CbGeAlD
Ziprasidone—HRH1—epithelium—ulcerative colitis	0.000794	0.00672	CbGeAlD
Ziprasidone—ADRA1A—lymphoid tissue—ulcerative colitis	0.00079	0.00669	CbGeAlD
Ziprasidone—HRH1—smooth muscle tissue—ulcerative colitis	0.000765	0.00648	CbGeAlD
Ziprasidone—HTR2A—epithelium—ulcerative colitis	0.000663	0.00561	CbGeAlD
Ziprasidone—CYP1A2—digestive system—ulcerative colitis	0.000645	0.00546	CbGeAlD
Ziprasidone—HTR2A—smooth muscle tissue—ulcerative colitis	0.000639	0.00541	CbGeAlD
Ziprasidone—CYP3A5—digestive system—ulcerative colitis	0.000623	0.00527	CbGeAlD
Ziprasidone—HRH1—digestive system—ulcerative colitis	0.000604	0.00511	CbGeAlD
Ziprasidone—HTR7—liver—ulcerative colitis	0.000603	0.0051	CbGeAlD
Ziprasidone—ADRA1A—liver—ulcerative colitis	0.000582	0.00492	CbGeAlD
Ziprasidone—ADRA2C—liver—ulcerative colitis	0.000554	0.00469	CbGeAlD
Ziprasidone—HTR2A—digestive system—ulcerative colitis	0.000505	0.00427	CbGeAlD
Ziprasidone—CYP1A2—liver—ulcerative colitis	0.000481	0.00407	CbGeAlD
Ziprasidone—CYP3A4—digestive system—ulcerative colitis	0.000467	0.00395	CbGeAlD
Ziprasidone—CYP3A5—liver—ulcerative colitis	0.000464	0.00393	CbGeAlD
Ziprasidone—CYP2D6—digestive system—ulcerative colitis	0.00046	0.00389	CbGeAlD
Ziprasidone—HTR2A—liver—ulcerative colitis	0.000376	0.00318	CbGeAlD
Ziprasidone—CYP3A4—liver—ulcerative colitis	0.000348	0.00295	CbGeAlD
Ziprasidone—CYP2D6—liver—ulcerative colitis	0.000343	0.0029	CbGeAlD
Ziprasidone—Hypertension—Hydrocortisone—ulcerative colitis	0.000144	0.000436	CcSEcCtD
Ziprasidone—Diarrhoea—Azathioprine—ulcerative colitis	0.000144	0.000436	CcSEcCtD
Ziprasidone—Angioedema—Triamcinolone—ulcerative colitis	0.000144	0.000435	CcSEcCtD
Ziprasidone—Haemoglobin—Prednisone—ulcerative colitis	0.000144	0.000434	CcSEcCtD
Ziprasidone—Angioedema—Methylprednisolone—ulcerative colitis	0.000144	0.000434	CcSEcCtD
Ziprasidone—Haemorrhage—Prednisone—ulcerative colitis	0.000143	0.000432	CcSEcCtD
Ziprasidone—Erythema—Dexamethasone—ulcerative colitis	0.000143	0.000432	CcSEcCtD
Ziprasidone—Erythema—Betamethasone—ulcerative colitis	0.000143	0.000432	CcSEcCtD
Ziprasidone—Myalgia—Hydrocortisone—ulcerative colitis	0.000142	0.00043	CcSEcCtD
Ziprasidone—Anxiety—Hydrocortisone—ulcerative colitis	0.000142	0.000429	CcSEcCtD
Ziprasidone—Vertigo—Triamcinolone—ulcerative colitis	0.000141	0.000428	CcSEcCtD
Ziprasidone—Hypersensitivity—Mesalazine—ulcerative colitis	0.000141	0.000427	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000141	0.000427	CcSEcCtD
Ziprasidone—Syncope—Triamcinolone—ulcerative colitis	0.000141	0.000427	CcSEcCtD
Ziprasidone—Vertigo—Methylprednisolone—ulcerative colitis	0.000141	0.000427	CcSEcCtD
Ziprasidone—Syncope—Methylprednisolone—ulcerative colitis	0.000141	0.000426	CcSEcCtD
Ziprasidone—Connective tissue disorder—Prednisone—ulcerative colitis	0.00014	0.000425	CcSEcCtD
Ziprasidone—Nausea—Budesonide—ulcerative colitis	0.00014	0.000424	CcSEcCtD
Ziprasidone—Dizziness—Azathioprine—ulcerative colitis	0.000139	0.000421	CcSEcCtD
Ziprasidone—Loss of consciousness—Triamcinolone—ulcerative colitis	0.000138	0.000418	CcSEcCtD
Ziprasidone—Loss of consciousness—Methylprednisolone—ulcerative colitis	0.000138	0.000417	CcSEcCtD
Ziprasidone—Asthenia—Mesalazine—ulcerative colitis	0.000138	0.000416	CcSEcCtD
Ziprasidone—Shock—Prednisolone—ulcerative colitis	0.000137	0.000416	CcSEcCtD
Ziprasidone—Cough—Triamcinolone—ulcerative colitis	0.000137	0.000415	CcSEcCtD
Ziprasidone—Tachycardia—Prednisolone—ulcerative colitis	0.000136	0.000412	CcSEcCtD
Ziprasidone—Hypertension—Triamcinolone—ulcerative colitis	0.000136	0.000411	CcSEcCtD
Ziprasidone—Hypertension—Methylprednisolone—ulcerative colitis	0.000136	0.00041	CcSEcCtD
Ziprasidone—Infection—Hydrocortisone—ulcerative colitis	0.000136	0.00041	CcSEcCtD
Ziprasidone—Hyperhidrosis—Prednisolone—ulcerative colitis	0.000135	0.000408	CcSEcCtD
Ziprasidone—Shock—Hydrocortisone—ulcerative colitis	0.000134	0.000406	CcSEcCtD
Ziprasidone—Myalgia—Triamcinolone—ulcerative colitis	0.000134	0.000405	CcSEcCtD
Ziprasidone—Vomiting—Azathioprine—ulcerative colitis	0.000134	0.000405	CcSEcCtD
Ziprasidone—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000134	0.000405	CcSEcCtD
Ziprasidone—Arthralgia—Methylprednisolone—ulcerative colitis	0.000134	0.000404	CcSEcCtD
Ziprasidone—Myalgia—Methylprednisolone—ulcerative colitis	0.000134	0.000404	CcSEcCtD
Ziprasidone—Eye disorder—Prednisone—ulcerative colitis	0.000134	0.000404	CcSEcCtD
Ziprasidone—Anxiety—Methylprednisolone—ulcerative colitis	0.000133	0.000403	CcSEcCtD
Ziprasidone—Tachycardia—Hydrocortisone—ulcerative colitis	0.000133	0.000403	CcSEcCtD
Ziprasidone—Rash—Azathioprine—ulcerative colitis	0.000133	0.000402	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000133	0.000402	CcSEcCtD
Ziprasidone—Dermatitis—Azathioprine—ulcerative colitis	0.000133	0.000401	CcSEcCtD
Ziprasidone—Skin disorder—Hydrocortisone—ulcerative colitis	0.000133	0.000401	CcSEcCtD
Ziprasidone—Headache—Azathioprine—ulcerative colitis	0.000132	0.000399	CcSEcCtD
Ziprasidone—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.000132	0.000399	CcSEcCtD
Ziprasidone—Diarrhoea—Mesalazine—ulcerative colitis	0.000131	0.000397	CcSEcCtD
Ziprasidone—Dry mouth—Triamcinolone—ulcerative colitis	0.000131	0.000396	CcSEcCtD
Ziprasidone—Angioedema—Dexamethasone—ulcerative colitis	0.000131	0.000395	CcSEcCtD
Ziprasidone—Angioedema—Betamethasone—ulcerative colitis	0.000131	0.000395	CcSEcCtD
Ziprasidone—Anorexia—Hydrocortisone—ulcerative colitis	0.00013	0.000393	CcSEcCtD
Ziprasidone—Angiopathy—Prednisone—ulcerative colitis	0.00013	0.000392	CcSEcCtD
Ziprasidone—Confusional state—Methylprednisolone—ulcerative colitis	0.000129	0.000391	CcSEcCtD
Ziprasidone—Immune system disorder—Prednisone—ulcerative colitis	0.000129	0.00039	CcSEcCtD
Ziprasidone—Vertigo—Betamethasone—ulcerative colitis	0.000128	0.000388	CcSEcCtD
Ziprasidone—Vertigo—Dexamethasone—ulcerative colitis	0.000128	0.000388	CcSEcCtD
Ziprasidone—Syncope—Betamethasone—ulcerative colitis	0.000128	0.000387	CcSEcCtD
Ziprasidone—Syncope—Dexamethasone—ulcerative colitis	0.000128	0.000387	CcSEcCtD
Ziprasidone—Arrhythmia—Prednisone—ulcerative colitis	0.000128	0.000386	CcSEcCtD
Ziprasidone—Infection—Triamcinolone—ulcerative colitis	0.000128	0.000386	CcSEcCtD
Ziprasidone—Hypotension—Hydrocortisone—ulcerative colitis	0.000127	0.000386	CcSEcCtD
Ziprasidone—Infection—Methylprednisolone—ulcerative colitis	0.000127	0.000385	CcSEcCtD
Ziprasidone—Dizziness—Mesalazine—ulcerative colitis	0.000127	0.000384	CcSEcCtD
Ziprasidone—Shock—Triamcinolone—ulcerative colitis	0.000126	0.000382	CcSEcCtD
Ziprasidone—Insomnia—Prednisolone—ulcerative colitis	0.000126	0.000382	CcSEcCtD
Ziprasidone—Alopecia—Prednisone—ulcerative colitis	0.000126	0.000382	CcSEcCtD
Ziprasidone—Shock—Methylprednisolone—ulcerative colitis	0.000126	0.000381	CcSEcCtD
Ziprasidone—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000126	0.00038	CcSEcCtD
Ziprasidone—Loss of consciousness—Betamethasone—ulcerative colitis	0.000126	0.00038	CcSEcCtD
Ziprasidone—Loss of consciousness—Dexamethasone—ulcerative colitis	0.000126	0.00038	CcSEcCtD
Ziprasidone—Paraesthesia—Prednisolone—ulcerative colitis	0.000125	0.000379	CcSEcCtD
Ziprasidone—Tachycardia—Triamcinolone—ulcerative colitis	0.000125	0.000379	CcSEcCtD
Ziprasidone—Mental disorder—Prednisone—ulcerative colitis	0.000125	0.000379	CcSEcCtD
Ziprasidone—Nausea—Azathioprine—ulcerative colitis	0.000125	0.000378	CcSEcCtD
Ziprasidone—Tachycardia—Methylprednisolone—ulcerative colitis	0.000125	0.000378	CcSEcCtD
Ziprasidone—Skin disorder—Methylprednisolone—ulcerative colitis	0.000125	0.000376	CcSEcCtD
Ziprasidone—Malnutrition—Prednisone—ulcerative colitis	0.000124	0.000376	CcSEcCtD
Ziprasidone—Erythema—Prednisone—ulcerative colitis	0.000124	0.000376	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000124	0.000376	CcSEcCtD
Ziprasidone—Hyperhidrosis—Triamcinolone—ulcerative colitis	0.000124	0.000376	CcSEcCtD
Ziprasidone—Hyperhidrosis—Methylprednisolone—ulcerative colitis	0.000124	0.000375	CcSEcCtD
Ziprasidone—Insomnia—Hydrocortisone—ulcerative colitis	0.000123	0.000373	CcSEcCtD
Ziprasidone—Hypertension—Dexamethasone—ulcerative colitis	0.000123	0.000373	CcSEcCtD
Ziprasidone—Hypertension—Betamethasone—ulcerative colitis	0.000123	0.000373	CcSEcCtD
Ziprasidone—Paraesthesia—Hydrocortisone—ulcerative colitis	0.000123	0.00037	CcSEcCtD
Ziprasidone—Vomiting—Mesalazine—ulcerative colitis	0.000122	0.000369	CcSEcCtD
Ziprasidone—Myalgia—Dexamethasone—ulcerative colitis	0.000122	0.000368	CcSEcCtD
Ziprasidone—Myalgia—Betamethasone—ulcerative colitis	0.000122	0.000368	CcSEcCtD
Ziprasidone—Anxiety—Betamethasone—ulcerative colitis	0.000121	0.000366	CcSEcCtD
Ziprasidone—Anxiety—Dexamethasone—ulcerative colitis	0.000121	0.000366	CcSEcCtD
Ziprasidone—Rash—Mesalazine—ulcerative colitis	0.000121	0.000366	CcSEcCtD
Ziprasidone—Dermatitis—Mesalazine—ulcerative colitis	0.000121	0.000365	CcSEcCtD
Ziprasidone—Headache—Mesalazine—ulcerative colitis	0.00012	0.000363	CcSEcCtD
Ziprasidone—Dyspepsia—Hydrocortisone—ulcerative colitis	0.00012	0.000363	CcSEcCtD
Ziprasidone—Hypotension—Methylprednisolone—ulcerative colitis	0.00012	0.000362	CcSEcCtD
Ziprasidone—Decreased appetite—Hydrocortisone—ulcerative colitis	0.000119	0.000359	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000118	0.000356	CcSEcCtD
Ziprasidone—Fatigue—Hydrocortisone—ulcerative colitis	0.000118	0.000356	CcSEcCtD
Ziprasidone—Vision blurred—Prednisone—ulcerative colitis	0.000117	0.000354	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.000117	0.000354	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.000117	0.000353	CcSEcCtD
Ziprasidone—Insomnia—Triamcinolone—ulcerative colitis	0.000116	0.000351	CcSEcCtD
Ziprasidone—Insomnia—Methylprednisolone—ulcerative colitis	0.000116	0.000351	CcSEcCtD
Ziprasidone—Infection—Dexamethasone—ulcerative colitis	0.000116	0.00035	CcSEcCtD
Ziprasidone—Infection—Betamethasone—ulcerative colitis	0.000116	0.00035	CcSEcCtD
Ziprasidone—Paraesthesia—Triamcinolone—ulcerative colitis	0.000115	0.000349	CcSEcCtD
Ziprasidone—Feeling abnormal—Prednisolone—ulcerative colitis	0.000115	0.000348	CcSEcCtD
Ziprasidone—Paraesthesia—Methylprednisolone—ulcerative colitis	0.000115	0.000348	CcSEcCtD
Ziprasidone—Anaemia—Prednisone—ulcerative colitis	0.000115	0.000348	CcSEcCtD
Ziprasidone—Shock—Dexamethasone—ulcerative colitis	0.000115	0.000347	CcSEcCtD
Ziprasidone—Shock—Betamethasone—ulcerative colitis	0.000115	0.000347	CcSEcCtD
Ziprasidone—Dyspnoea—Triamcinolone—ulcerative colitis	0.000115	0.000346	CcSEcCtD
Ziprasidone—Nervous system disorder—Betamethasone—ulcerative colitis	0.000114	0.000346	CcSEcCtD
Ziprasidone—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000114	0.000346	CcSEcCtD
Ziprasidone—Agitation—Prednisone—ulcerative colitis	0.000114	0.000346	CcSEcCtD
Ziprasidone—Thrombocytopenia—Dexamethasone—ulcerative colitis	0.000114	0.000345	CcSEcCtD
Ziprasidone—Thrombocytopenia—Betamethasone—ulcerative colitis	0.000114	0.000345	CcSEcCtD
Ziprasidone—Nausea—Mesalazine—ulcerative colitis	0.000114	0.000345	CcSEcCtD
Ziprasidone—Tachycardia—Dexamethasone—ulcerative colitis	0.000114	0.000344	CcSEcCtD
Ziprasidone—Tachycardia—Betamethasone—ulcerative colitis	0.000114	0.000344	CcSEcCtD
Ziprasidone—Angioedema—Prednisone—ulcerative colitis	0.000114	0.000344	CcSEcCtD
Ziprasidone—Dyspepsia—Triamcinolone—ulcerative colitis	0.000113	0.000342	CcSEcCtD
Ziprasidone—Dyspepsia—Methylprednisolone—ulcerative colitis	0.000113	0.000341	CcSEcCtD
Ziprasidone—Hyperhidrosis—Dexamethasone—ulcerative colitis	0.000113	0.000341	CcSEcCtD
Ziprasidone—Hyperhidrosis—Betamethasone—ulcerative colitis	0.000113	0.000341	CcSEcCtD
Ziprasidone—Feeling abnormal—Hydrocortisone—ulcerative colitis	0.000112	0.00034	CcSEcCtD
Ziprasidone—Vertigo—Prednisone—ulcerative colitis	0.000112	0.000338	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000112	0.000337	CcSEcCtD
Ziprasidone—Syncope—Prednisone—ulcerative colitis	0.000112	0.000337	CcSEcCtD
Ziprasidone—Anorexia—Dexamethasone—ulcerative colitis	0.000111	0.000336	CcSEcCtD
Ziprasidone—Anorexia—Betamethasone—ulcerative colitis	0.000111	0.000336	CcSEcCtD
Ziprasidone—Urticaria—Prednisolone—ulcerative colitis	0.000111	0.000336	CcSEcCtD
Ziprasidone—Fatigue—Triamcinolone—ulcerative colitis	0.000111	0.000335	CcSEcCtD
Ziprasidone—Fatigue—Methylprednisolone—ulcerative colitis	0.000111	0.000334	CcSEcCtD
Ziprasidone—Loss of consciousness—Prednisone—ulcerative colitis	0.000109	0.000331	CcSEcCtD
Ziprasidone—Hypotension—Dexamethasone—ulcerative colitis	0.000109	0.000329	CcSEcCtD
Ziprasidone—Hypotension—Betamethasone—ulcerative colitis	0.000109	0.000329	CcSEcCtD
Ziprasidone—Urticaria—Hydrocortisone—ulcerative colitis	0.000108	0.000328	CcSEcCtD
Ziprasidone—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000108	0.000326	CcSEcCtD
Ziprasidone—Body temperature increased—Hydrocortisone—ulcerative colitis	0.000108	0.000326	CcSEcCtD
Ziprasidone—Hypertension—Prednisone—ulcerative colitis	0.000107	0.000325	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.000106	0.000321	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.000106	0.000321	CcSEcCtD
Ziprasidone—Myalgia—Prednisone—ulcerative colitis	0.000106	0.00032	CcSEcCtD
Ziprasidone—Arthralgia—Prednisone—ulcerative colitis	0.000106	0.00032	CcSEcCtD
Ziprasidone—Feeling abnormal—Triamcinolone—ulcerative colitis	0.000106	0.00032	CcSEcCtD
Ziprasidone—Feeling abnormal—Methylprednisolone—ulcerative colitis	0.000106	0.000319	CcSEcCtD
Ziprasidone—Anxiety—Prednisone—ulcerative colitis	0.000106	0.000319	CcSEcCtD
Ziprasidone—Insomnia—Dexamethasone—ulcerative colitis	0.000105	0.000319	CcSEcCtD
Ziprasidone—Insomnia—Betamethasone—ulcerative colitis	0.000105	0.000319	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000105	0.000318	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000105	0.000317	CcSEcCtD
Ziprasidone—Paraesthesia—Dexamethasone—ulcerative colitis	0.000105	0.000317	CcSEcCtD
Ziprasidone—Paraesthesia—Betamethasone—ulcerative colitis	0.000105	0.000317	CcSEcCtD
Ziprasidone—Hypersensitivity—Prednisolone—ulcerative colitis	0.000103	0.000311	CcSEcCtD
Ziprasidone—Dyspepsia—Betamethasone—ulcerative colitis	0.000103	0.00031	CcSEcCtD
Ziprasidone—Dyspepsia—Dexamethasone—ulcerative colitis	0.000103	0.00031	CcSEcCtD
Ziprasidone—Urticaria—Triamcinolone—ulcerative colitis	0.000102	0.000309	CcSEcCtD
Ziprasidone—Urticaria—Methylprednisolone—ulcerative colitis	0.000102	0.000308	CcSEcCtD
Ziprasidone—Body temperature increased—Triamcinolone—ulcerative colitis	0.000102	0.000307	CcSEcCtD
Ziprasidone—Abdominal pain—Methylprednisolone—ulcerative colitis	0.000101	0.000306	CcSEcCtD
Ziprasidone—Decreased appetite—Dexamethasone—ulcerative colitis	0.000101	0.000306	CcSEcCtD
Ziprasidone—Decreased appetite—Betamethasone—ulcerative colitis	0.000101	0.000306	CcSEcCtD
Ziprasidone—Infection—Prednisone—ulcerative colitis	0.000101	0.000305	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000101	0.000304	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000101	0.000304	CcSEcCtD
Ziprasidone—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.000101	0.000304	CcSEcCtD
Ziprasidone—Fatigue—Dexamethasone—ulcerative colitis	0.000101	0.000304	CcSEcCtD
Ziprasidone—Fatigue—Betamethasone—ulcerative colitis	0.000101	0.000304	CcSEcCtD
Ziprasidone—Shock—Prednisone—ulcerative colitis	9.99e-05	0.000302	CcSEcCtD
Ziprasidone—Nervous system disorder—Prednisone—ulcerative colitis	9.96e-05	0.000301	CcSEcCtD
Ziprasidone—Tachycardia—Prednisone—ulcerative colitis	9.91e-05	0.0003	CcSEcCtD
Ziprasidone—Skin disorder—Prednisone—ulcerative colitis	9.86e-05	0.000298	CcSEcCtD
Ziprasidone—Hyperhidrosis—Prednisone—ulcerative colitis	9.81e-05	0.000297	CcSEcCtD
Ziprasidone—Asthenia—Hydrocortisone—ulcerative colitis	9.79e-05	0.000296	CcSEcCtD
Ziprasidone—Anorexia—Prednisone—ulcerative colitis	9.68e-05	0.000293	CcSEcCtD
Ziprasidone—Feeling abnormal—Betamethasone—ulcerative colitis	9.61e-05	0.00029	CcSEcCtD
Ziprasidone—Feeling abnormal—Dexamethasone—ulcerative colitis	9.61e-05	0.00029	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Betamethasone—ulcerative colitis	9.53e-05	0.000288	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Dexamethasone—ulcerative colitis	9.53e-05	0.000288	CcSEcCtD
Ziprasidone—Hypersensitivity—Triamcinolone—ulcerative colitis	9.47e-05	0.000286	CcSEcCtD
Ziprasidone—Hypersensitivity—Methylprednisolone—ulcerative colitis	9.44e-05	0.000286	CcSEcCtD
Ziprasidone—Diarrhoea—Hydrocortisone—ulcerative colitis	9.34e-05	0.000282	CcSEcCtD
Ziprasidone—Urticaria—Betamethasone—ulcerative colitis	9.26e-05	0.00028	CcSEcCtD
Ziprasidone—Urticaria—Dexamethasone—ulcerative colitis	9.26e-05	0.00028	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Prednisone—ulcerative colitis	9.25e-05	0.00028	CcSEcCtD
Ziprasidone—Dizziness—Prednisolone—ulcerative colitis	9.24e-05	0.000279	CcSEcCtD
Ziprasidone—Asthenia—Triamcinolone—ulcerative colitis	9.22e-05	0.000279	CcSEcCtD
Ziprasidone—Abdominal pain—Dexamethasone—ulcerative colitis	9.22e-05	0.000279	CcSEcCtD
Ziprasidone—Abdominal pain—Betamethasone—ulcerative colitis	9.22e-05	0.000279	CcSEcCtD
Ziprasidone—Body temperature increased—Dexamethasone—ulcerative colitis	9.22e-05	0.000279	CcSEcCtD
Ziprasidone—Body temperature increased—Betamethasone—ulcerative colitis	9.22e-05	0.000279	CcSEcCtD
Ziprasidone—Asthenia—Methylprednisolone—ulcerative colitis	9.2e-05	0.000278	CcSEcCtD
Ziprasidone—Insomnia—Prednisone—ulcerative colitis	9.18e-05	0.000278	CcSEcCtD
Ziprasidone—Paraesthesia—Prednisone—ulcerative colitis	9.12e-05	0.000276	CcSEcCtD
Ziprasidone—Dizziness—Hydrocortisone—ulcerative colitis	9.02e-05	0.000273	CcSEcCtD
Ziprasidone—Dyspepsia—Prednisone—ulcerative colitis	8.94e-05	0.00027	CcSEcCtD
Ziprasidone—Decreased appetite—Prednisone—ulcerative colitis	8.83e-05	0.000267	CcSEcCtD
Ziprasidone—Rash—Prednisolone—ulcerative colitis	8.81e-05	0.000266	CcSEcCtD
Ziprasidone—Dermatitis—Prednisolone—ulcerative colitis	8.8e-05	0.000266	CcSEcCtD
Ziprasidone—Diarrhoea—Methylprednisolone—ulcerative colitis	8.77e-05	0.000265	CcSEcCtD
Ziprasidone—Fatigue—Prednisone—ulcerative colitis	8.75e-05	0.000265	CcSEcCtD
Ziprasidone—Headache—Prednisolone—ulcerative colitis	8.75e-05	0.000265	CcSEcCtD
Ziprasidone—Constipation—Prednisone—ulcerative colitis	8.68e-05	0.000262	CcSEcCtD
Ziprasidone—Vomiting—Hydrocortisone—ulcerative colitis	8.68e-05	0.000262	CcSEcCtD
Ziprasidone—Rash—Hydrocortisone—ulcerative colitis	8.6e-05	0.00026	CcSEcCtD
Ziprasidone—Dermatitis—Hydrocortisone—ulcerative colitis	8.6e-05	0.00026	CcSEcCtD
Ziprasidone—Headache—Hydrocortisone—ulcerative colitis	8.55e-05	0.000258	CcSEcCtD
Ziprasidone—Dizziness—Triamcinolone—ulcerative colitis	8.5e-05	0.000257	CcSEcCtD
Ziprasidone—Dizziness—Methylprednisolone—ulcerative colitis	8.48e-05	0.000256	CcSEcCtD
Ziprasidone—Feeling abnormal—Prednisone—ulcerative colitis	8.37e-05	0.000253	CcSEcCtD
Ziprasidone—Asthenia—Dexamethasone—ulcerative colitis	8.36e-05	0.000253	CcSEcCtD
Ziprasidone—Asthenia—Betamethasone—ulcerative colitis	8.36e-05	0.000253	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Prednisone—ulcerative colitis	8.3e-05	0.000251	CcSEcCtD
Ziprasidone—Nausea—Prednisolone—ulcerative colitis	8.3e-05	0.000251	CcSEcCtD
Ziprasidone—Vomiting—Triamcinolone—ulcerative colitis	8.17e-05	0.000247	CcSEcCtD
Ziprasidone—Vomiting—Methylprednisolone—ulcerative colitis	8.15e-05	0.000246	CcSEcCtD
Ziprasidone—Nausea—Hydrocortisone—ulcerative colitis	8.1e-05	0.000245	CcSEcCtD
Ziprasidone—Rash—Triamcinolone—ulcerative colitis	8.1e-05	0.000245	CcSEcCtD
Ziprasidone—Dermatitis—Triamcinolone—ulcerative colitis	8.09e-05	0.000245	CcSEcCtD
Ziprasidone—Rash—Methylprednisolone—ulcerative colitis	8.08e-05	0.000244	CcSEcCtD
Ziprasidone—Dermatitis—Methylprednisolone—ulcerative colitis	8.08e-05	0.000244	CcSEcCtD
Ziprasidone—Urticaria—Prednisone—ulcerative colitis	8.06e-05	0.000244	CcSEcCtD
Ziprasidone—Headache—Triamcinolone—ulcerative colitis	8.05e-05	0.000243	CcSEcCtD
Ziprasidone—Headache—Methylprednisolone—ulcerative colitis	8.03e-05	0.000243	CcSEcCtD
Ziprasidone—Body temperature increased—Prednisone—ulcerative colitis	8.03e-05	0.000243	CcSEcCtD
Ziprasidone—Abdominal pain—Prednisone—ulcerative colitis	8.03e-05	0.000243	CcSEcCtD
Ziprasidone—Diarrhoea—Dexamethasone—ulcerative colitis	7.98e-05	0.000241	CcSEcCtD
Ziprasidone—Diarrhoea—Betamethasone—ulcerative colitis	7.98e-05	0.000241	CcSEcCtD
Ziprasidone—Dizziness—Betamethasone—ulcerative colitis	7.71e-05	0.000233	CcSEcCtD
Ziprasidone—Dizziness—Dexamethasone—ulcerative colitis	7.71e-05	0.000233	CcSEcCtD
Ziprasidone—Nausea—Triamcinolone—ulcerative colitis	7.63e-05	0.000231	CcSEcCtD
Ziprasidone—Nausea—Methylprednisolone—ulcerative colitis	7.61e-05	0.00023	CcSEcCtD
Ziprasidone—Hypersensitivity—Prednisone—ulcerative colitis	7.48e-05	0.000226	CcSEcCtD
Ziprasidone—Vomiting—Betamethasone—ulcerative colitis	7.41e-05	0.000224	CcSEcCtD
Ziprasidone—Vomiting—Dexamethasone—ulcerative colitis	7.41e-05	0.000224	CcSEcCtD
Ziprasidone—Rash—Dexamethasone—ulcerative colitis	7.35e-05	0.000222	CcSEcCtD
Ziprasidone—Rash—Betamethasone—ulcerative colitis	7.35e-05	0.000222	CcSEcCtD
Ziprasidone—Dermatitis—Betamethasone—ulcerative colitis	7.34e-05	0.000222	CcSEcCtD
Ziprasidone—Dermatitis—Dexamethasone—ulcerative colitis	7.34e-05	0.000222	CcSEcCtD
Ziprasidone—Headache—Dexamethasone—ulcerative colitis	7.3e-05	0.000221	CcSEcCtD
Ziprasidone—Headache—Betamethasone—ulcerative colitis	7.3e-05	0.000221	CcSEcCtD
Ziprasidone—Asthenia—Prednisone—ulcerative colitis	7.28e-05	0.00022	CcSEcCtD
Ziprasidone—Diarrhoea—Prednisone—ulcerative colitis	6.95e-05	0.00021	CcSEcCtD
Ziprasidone—Nausea—Betamethasone—ulcerative colitis	6.92e-05	0.000209	CcSEcCtD
Ziprasidone—Nausea—Dexamethasone—ulcerative colitis	6.92e-05	0.000209	CcSEcCtD
Ziprasidone—Dizziness—Prednisone—ulcerative colitis	6.71e-05	0.000203	CcSEcCtD
Ziprasidone—Vomiting—Prednisone—ulcerative colitis	6.45e-05	0.000195	CcSEcCtD
Ziprasidone—Rash—Prednisone—ulcerative colitis	6.4e-05	0.000194	CcSEcCtD
Ziprasidone—Dermatitis—Prednisone—ulcerative colitis	6.4e-05	0.000193	CcSEcCtD
Ziprasidone—Headache—Prednisone—ulcerative colitis	6.36e-05	0.000192	CcSEcCtD
Ziprasidone—Aripiprazole—ABCB1—ulcerative colitis	6.12e-05	0.395	CrCbGaD
Ziprasidone—Trazodone—ABCB1—ulcerative colitis	6.09e-05	0.393	CrCbGaD
Ziprasidone—Nausea—Prednisone—ulcerative colitis	6.03e-05	0.000182	CcSEcCtD
Ziprasidone—Clozapine—ABCB1—ulcerative colitis	3.29e-05	0.212	CrCbGaD
Ziprasidone—DRD1—Signaling Pathways—JAK2—ulcerative colitis	8.97e-06	5.41e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—IL2—ulcerative colitis	8.95e-06	5.4e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—JAK2—ulcerative colitis	8.85e-06	5.34e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—CALM3—ulcerative colitis	8.85e-06	5.34e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—IL2—ulcerative colitis	8.84e-06	5.33e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling by GPCR—IL6—ulcerative colitis	8.79e-06	5.3e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—IL2—ulcerative colitis	8.69e-06	5.25e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—RELA—ulcerative colitis	8.69e-06	5.24e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—PPARG—ulcerative colitis	8.68e-06	5.24e-05	CbGpPWpGaD
Ziprasidone—CYP3A7—Metabolism—PTGS2—ulcerative colitis	8.65e-06	5.22e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling by GPCR—IL6—ulcerative colitis	8.65e-06	5.22e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—MMP9—ulcerative colitis	8.61e-06	5.19e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—MMP9—ulcerative colitis	8.6e-06	5.19e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—CXCL8—ulcerative colitis	8.59e-06	5.19e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—IL2—ulcerative colitis	8.58e-06	5.18e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—RELA—ulcerative colitis	8.58e-06	5.17e-05	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—TP53—ulcerative colitis	8.55e-06	5.16e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—MMP9—ulcerative colitis	8.54e-06	5.15e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling by GPCR—IL6—ulcerative colitis	8.53e-06	5.15e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—NFKB1—ulcerative colitis	8.51e-06	5.14e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—NFKB1—ulcerative colitis	8.5e-06	5.13e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—ALB—ulcerative colitis	8.5e-06	5.13e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	8.46e-06	5.11e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—NFKB1—ulcerative colitis	8.45e-06	5.1e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Metabolism—PTGS2—ulcerative colitis	8.4e-06	5.07e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—MMP9—ulcerative colitis	8.36e-06	5.05e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—NFKB1—ulcerative colitis	8.27e-06	4.99e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—MMP9—ulcerative colitis	8.23e-06	4.97e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—IL2—ulcerative colitis	8.21e-06	4.96e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—CXCL8—ulcerative colitis	8.19e-06	4.94e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling by GPCR—IL6—ulcerative colitis	8.17e-06	4.93e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—NFKB1—ulcerative colitis	8.14e-06	4.91e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—ABCB1—ulcerative colitis	8.13e-06	4.9e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—MMP9—ulcerative colitis	8.12e-06	4.9e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—CXCL8—ulcerative colitis	8.08e-06	4.88e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—NFKB1—ulcerative colitis	8.03e-06	4.85e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—JAK2—ulcerative colitis	7.99e-06	4.82e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—PPARG—ulcerative colitis	7.95e-06	4.8e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—IL2—ulcerative colitis	7.83e-06	4.72e-05	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—IL6—ulcerative colitis	7.82e-06	4.72e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—ALB—ulcerative colitis	7.8e-06	4.71e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling by GPCR—IL6—ulcerative colitis	7.79e-06	4.7e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—MMP9—ulcerative colitis	7.77e-06	4.69e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—RELA—ulcerative colitis	7.74e-06	4.67e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—IL2—ulcerative colitis	7.72e-06	4.66e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—JAK2—ulcerative colitis	7.72e-06	4.66e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—NFKB1—ulcerative colitis	7.69e-06	4.64e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling by GPCR—IL6—ulcerative colitis	7.68e-06	4.64e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—JAK2—ulcerative colitis	7.68e-06	4.63e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—STAT3—ulcerative colitis	7.65e-06	4.62e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—STAT3—ulcerative colitis	7.64e-06	4.61e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—STAT3—ulcerative colitis	7.59e-06	4.58e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PTGS1—ulcerative colitis	7.59e-06	4.58e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—ADCY5—ulcerative colitis	7.58e-06	4.57e-05	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—TP53—ulcerative colitis	7.56e-06	4.56e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—RELA—ulcerative colitis	7.47e-06	4.51e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—JAK2—ulcerative colitis	7.47e-06	4.51e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—PTGS2—ulcerative colitis	7.44e-06	4.49e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—STAT3—ulcerative colitis	7.43e-06	4.49e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—RELA—ulcerative colitis	7.43e-06	4.49e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—MMP9—ulcerative colitis	7.41e-06	4.47e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—JAK2—ulcerative colitis	7.35e-06	4.43e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—NFKB1—ulcerative colitis	7.33e-06	4.42e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—STAT3—ulcerative colitis	7.32e-06	4.41e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—MMP9—ulcerative colitis	7.31e-06	4.41e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—CXCL8—ulcerative colitis	7.3e-06	4.4e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—RELA—ulcerative colitis	7.23e-06	4.36e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—NFKB1—ulcerative colitis	7.23e-06	4.36e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—STAT3—ulcerative colitis	7.22e-06	4.36e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—ALB—ulcerative colitis	7.15e-06	4.31e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—RELA—ulcerative colitis	7.12e-06	4.29e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—TGFB1—ulcerative colitis	7.09e-06	4.28e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—TGFB1—ulcerative colitis	7.08e-06	4.28e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—CXCL8—ulcerative colitis	7.04e-06	4.25e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—TGFB1—ulcerative colitis	7.04e-06	4.25e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—CXCL8—ulcerative colitis	7.01e-06	4.23e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—IL2—ulcerative colitis	6.97e-06	4.21e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling by GPCR—IL6—ulcerative colitis	6.94e-06	4.19e-05	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—IL6—ulcerative colitis	6.92e-06	4.18e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—STAT3—ulcerative colitis	6.91e-06	4.17e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—TGFB1—ulcerative colitis	6.89e-06	4.16e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—ABCB1—ulcerative colitis	6.88e-06	4.15e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—CALM3—ulcerative colitis	6.83e-06	4.12e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—PTGS2—ulcerative colitis	6.83e-06	4.12e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—CXCL8—ulcerative colitis	6.81e-06	4.11e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—TGFB1—ulcerative colitis	6.78e-06	4.09e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—JAK2—ulcerative colitis	6.78e-06	4.09e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—IL2—ulcerative colitis	6.73e-06	4.06e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—CXCL8—ulcerative colitis	6.71e-06	4.05e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling by GPCR—IL6—ulcerative colitis	6.7e-06	4.04e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—IL2—ulcerative colitis	6.7e-06	4.04e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—TGFB1—ulcerative colitis	6.69e-06	4.04e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—JAK2—ulcerative colitis	6.67e-06	4.02e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling by GPCR—IL6—ulcerative colitis	6.66e-06	4.02e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—JAK2—ulcerative colitis	6.65e-06	4.01e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—JAK2—ulcerative colitis	6.63e-06	4e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—JAK2—ulcerative colitis	6.61e-06	3.99e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—MMP9—ulcerative colitis	6.6e-06	3.98e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—STAT3—ulcerative colitis	6.59e-06	3.97e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—RELA—ulcerative colitis	6.56e-06	3.96e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—JAK2—ulcerative colitis	6.55e-06	3.95e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—NFKB1—ulcerative colitis	6.53e-06	3.94e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—JAK2—ulcerative colitis	6.53e-06	3.94e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—IL2—ulcerative colitis	6.51e-06	3.93e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—STAT3—ulcerative colitis	6.5e-06	3.92e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling by GPCR—IL6—ulcerative colitis	6.48e-06	3.91e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—RELA—ulcerative colitis	6.46e-06	3.9e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—RELA—ulcerative colitis	6.44e-06	3.89e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—ADCY5—ulcerative colitis	6.42e-06	3.88e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—RELA—ulcerative colitis	6.42e-06	3.88e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—IL2—ulcerative colitis	6.41e-06	3.87e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—TGFB1—ulcerative colitis	6.41e-06	3.87e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—RELA—ulcerative colitis	6.4e-06	3.86e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling by GPCR—IL6—ulcerative colitis	6.38e-06	3.85e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—MMP9—ulcerative colitis	6.37e-06	3.84e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—RELA—ulcerative colitis	6.34e-06	3.83e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—MMP9—ulcerative colitis	6.34e-06	3.82e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—RELA—ulcerative colitis	6.32e-06	3.81e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—NFKB1—ulcerative colitis	6.3e-06	3.8e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—NFKB1—ulcerative colitis	6.27e-06	3.78e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—PTGS2—ulcerative colitis	6.25e-06	3.77e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—CXCL8—ulcerative colitis	6.18e-06	3.73e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—MMP9—ulcerative colitis	6.16e-06	3.72e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—TGFB1—ulcerative colitis	6.11e-06	3.68e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—NFKB1—ulcerative colitis	6.1e-06	3.68e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—CXCL8—ulcerative colitis	6.08e-06	3.67e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—CXCL8—ulcerative colitis	6.07e-06	3.66e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—MMP9—ulcerative colitis	6.07e-06	3.66e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—JAK2—ulcerative colitis	6.06e-06	3.66e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—CXCL8—ulcerative colitis	6.05e-06	3.65e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—CXCL8—ulcerative colitis	6.03e-06	3.64e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—TGFB1—ulcerative colitis	6.02e-06	3.64e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—NFKB1—ulcerative colitis	6e-06	3.62e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CXCL8—ulcerative colitis	5.97e-06	3.6e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CXCL8—ulcerative colitis	5.96e-06	3.59e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—IL2—ulcerative colitis	5.91e-06	3.57e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling by GPCR—IL6—ulcerative colitis	5.88e-06	3.55e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—RELA—ulcerative colitis	5.87e-06	3.54e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—STAT3—ulcerative colitis	5.87e-06	3.54e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—TP53—ulcerative colitis	5.84e-06	3.52e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—TP53—ulcerative colitis	5.83e-06	3.52e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—IL2—ulcerative colitis	5.81e-06	3.51e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—IL2—ulcerative colitis	5.8e-06	3.5e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—TP53—ulcerative colitis	5.79e-06	3.5e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling by GPCR—IL6—ulcerative colitis	5.79e-06	3.49e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—IL2—ulcerative colitis	5.78e-06	3.49e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—IL6—ulcerative colitis	5.77e-06	3.48e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—IL2—ulcerative colitis	5.77e-06	3.48e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—IL6—ulcerative colitis	5.75e-06	3.47e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—IL6—ulcerative colitis	5.74e-06	3.46e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—IL2—ulcerative colitis	5.71e-06	3.45e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—IL2—ulcerative colitis	5.69e-06	3.44e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—IL6—ulcerative colitis	5.68e-06	3.43e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—TP53—ulcerative colitis	5.67e-06	3.42e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—IL6—ulcerative colitis	5.66e-06	3.42e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—STAT3—ulcerative colitis	5.66e-06	3.42e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—PPARG—ulcerative colitis	5.65e-06	3.41e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—STAT3—ulcerative colitis	5.63e-06	3.4e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—MMP9—ulcerative colitis	5.59e-06	3.37e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—TP53—ulcerative colitis	5.58e-06	3.37e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CXCL8—ulcerative colitis	5.54e-06	3.34e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—NFKB1—ulcerative colitis	5.53e-06	3.34e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—TP53—ulcerative colitis	5.51e-06	3.32e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—MMP9—ulcerative colitis	5.5e-06	3.32e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—MMP9—ulcerative colitis	5.49e-06	3.31e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—STAT3—ulcerative colitis	5.48e-06	3.31e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—MMP9—ulcerative colitis	5.47e-06	3.3e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—MMP9—ulcerative colitis	5.46e-06	3.29e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—NFKB1—ulcerative colitis	5.44e-06	3.29e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—TGFB1—ulcerative colitis	5.44e-06	3.28e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—NFKB1—ulcerative colitis	5.43e-06	3.28e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—NFKB1—ulcerative colitis	5.42e-06	3.27e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—MMP9—ulcerative colitis	5.4e-06	3.26e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—NFKB1—ulcerative colitis	5.4e-06	3.26e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—STAT3—ulcerative colitis	5.39e-06	3.25e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—MMP9—ulcerative colitis	5.39e-06	3.25e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—NFKB1—ulcerative colitis	5.35e-06	3.23e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—IL6—ulcerative colitis	5.34e-06	3.23e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—IL6—ulcerative colitis	5.34e-06	3.22e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—NFKB1—ulcerative colitis	5.33e-06	3.22e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—ABCB1—ulcerative colitis	5.31e-06	3.21e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—IL6—ulcerative colitis	5.3e-06	3.2e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—IL2—ulcerative colitis	5.29e-06	3.19e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—TP53—ulcerative colitis	5.27e-06	3.18e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—IL6—ulcerative colitis	5.26e-06	3.18e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—TGFB1—ulcerative colitis	5.25e-06	3.17e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—TGFB1—ulcerative colitis	5.22e-06	3.15e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—IL6—ulcerative colitis	5.19e-06	3.13e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—IL6—ulcerative colitis	5.11e-06	3.08e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—ALB—ulcerative colitis	5.08e-06	3.07e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—TGFB1—ulcerative colitis	5.08e-06	3.07e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—IL6—ulcerative colitis	5.04e-06	3.04e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—TP53—ulcerative colitis	5.03e-06	3.03e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—MMP9—ulcerative colitis	5.01e-06	3.02e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—TGFB1—ulcerative colitis	5e-06	3.02e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—STAT3—ulcerative colitis	4.97e-06	3e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—TP53—ulcerative colitis	4.96e-06	2.99e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—ADCY5—ulcerative colitis	4.96e-06	2.99e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—NFKB1—ulcerative colitis	4.95e-06	2.99e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—STAT3—ulcerative colitis	4.89e-06	2.95e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—STAT3—ulcerative colitis	4.88e-06	2.95e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—STAT3—ulcerative colitis	4.87e-06	2.94e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—STAT3—ulcerative colitis	4.85e-06	2.93e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—IL6—ulcerative colitis	4.83e-06	2.91e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—STAT3—ulcerative colitis	4.8e-06	2.9e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—STAT3—ulcerative colitis	4.79e-06	2.89e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—PPARG—ulcerative colitis	4.79e-06	2.89e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—TGFB1—ulcerative colitis	4.61e-06	2.78e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—IL6—ulcerative colitis	4.6e-06	2.78e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—IL6—ulcerative colitis	4.54e-06	2.74e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—TGFB1—ulcerative colitis	4.54e-06	2.74e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—TGFB1—ulcerative colitis	4.53e-06	2.73e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—TGFB1—ulcerative colitis	4.51e-06	2.72e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—TGFB1—ulcerative colitis	4.5e-06	2.71e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—TP53—ulcerative colitis	4.48e-06	2.7e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—TGFB1—ulcerative colitis	4.45e-06	2.69e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—STAT3—ulcerative colitis	4.45e-06	2.69e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—PTGS2—ulcerative colitis	4.45e-06	2.68e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—TGFB1—ulcerative colitis	4.44e-06	2.68e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—TP53—ulcerative colitis	4.32e-06	2.61e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—ALB—ulcerative colitis	4.31e-06	2.6e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—TP53—ulcerative colitis	4.3e-06	2.59e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—TP53—ulcerative colitis	4.18e-06	2.52e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—TGFB1—ulcerative colitis	4.13e-06	2.49e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—TP53—ulcerative colitis	4.12e-06	2.48e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—IL6—ulcerative colitis	4.1e-06	2.47e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—IL6—ulcerative colitis	3.96e-06	2.39e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—IL6—ulcerative colitis	3.94e-06	2.37e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—IL6—ulcerative colitis	3.83e-06	2.31e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—TP53—ulcerative colitis	3.79e-06	2.29e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—PTGS2—ulcerative colitis	3.77e-06	2.27e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—IL6—ulcerative colitis	3.77e-06	2.27e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—TP53—ulcerative colitis	3.73e-06	2.25e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—TP53—ulcerative colitis	3.73e-06	2.25e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—TP53—ulcerative colitis	3.71e-06	2.24e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—TP53—ulcerative colitis	3.7e-06	2.23e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PPARG—ulcerative colitis	3.7e-06	2.23e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—TP53—ulcerative colitis	3.67e-06	2.21e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—TP53—ulcerative colitis	3.66e-06	2.21e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—IL6—ulcerative colitis	3.47e-06	2.1e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—IL6—ulcerative colitis	3.42e-06	2.06e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—IL6—ulcerative colitis	3.41e-06	2.06e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—IL6—ulcerative colitis	3.4e-06	2.05e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—TP53—ulcerative colitis	3.4e-06	2.05e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—IL6—ulcerative colitis	3.39e-06	2.04e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—IL6—ulcerative colitis	3.36e-06	2.02e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—IL6—ulcerative colitis	3.35e-06	2.02e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—ALB—ulcerative colitis	3.32e-06	2.01e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—IL6—ulcerative colitis	3.11e-06	1.88e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PTGS2—ulcerative colitis	2.91e-06	1.75e-05	CbGpPWpGaD
